UTI-Healthcare Fund – Direct Growth

Equity . Sectoral / Thematic

Scheme Performance

1Y 3Y 5Y Max
Fund Returns -6.36% 23.61% 12.70% 13.83%
Category Average -6.73% -5.30% 10.17% -

Returns Calculator

UTI-Healthcare Fund – Direct Growth
Monthly Amount Invested
Duration
Would Have Become
  • --
    Invested Value
  • --
    Current Value
  • --
    Total Gain
Returns : --
per annum

Scheme Information

0.95
Expense Ratio
766 Cr
Scheme Size
9 Years
Age of Fund
Exit Load 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment.
Fund Managers V Srivatsa
Benchmark S&P BSE Healthcare TRI
Scheme Obejctive The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Lock-in N/A
Risk Very High
Alpha
-0.03
Beta
0.54
Sharpe
0.00
SD
0.91

Scheme Allocation

By Holdings

Sun Pharma.Inds. 10.71%
Dr Reddy's Labs 7.99%
Cipla 7.85%
Divi's Lab. 5.25%
Fortis Health. 4.97%
View all Holdings

By Sector

Healthcare Services 17.57%
Cash & Others 1.23%
Others 0.28%
Debt 0.17%

By Assets

Equity 98.34%
Net Curr Ass/Net Receivables 1.23%
Fixed Deposit 0.28%
T-Bills 0.17%

AMC Details

UTI Mutual Fund
AUM:
2,23,842 Cr
Address:
UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051
Contact:
66786666
Email ID:
service@uti.co.in

Frequently Asked Questions

The NAV of UTI-Healthcare Fund – Direct Growth is ₹160.88 as of 20 May 2022.